21/08/2026
We are committed to having relevant and informative conversations about all aspects of our industry.
As can be seen by this week's BAS newsletter where Richard Oliver provides an expert account of what to consider when dealing with adverse drug reactions (ADRs) in patients.
These are the conversations which help to keep our industry accountable and elevate the standard of care, and results, for patients.
This is also the standard of information you can expect at the BAS 2027 Annual Conference - we are enjoying inviting the best voices in our field to share their expertise.
To stay in the loop with all future topics and the BAS Conference updates, you can join the newsletter via our website.